17 Aug 2021 Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies Member news
28 Jul 2021 Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Member news
27 Jul 2021 eTheRNA immunotherapies appoints Mathieu Lane as Chief Financial Officer and President of eTheRNA Inc. located in the U.S.A Member news
15 Jul 2021 Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands Member news
15 Jul 2021 ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments Member news
15 Jul 2021 Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study Member news
15 Jul 2021 Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
